Breaking News Instant updates and real-time market news.

MDCO

The Medicines Co.

$41.92

-1.05 (-2.44%)

07:21
09/03/19
09/03
07:21
09/03/19
07:21

The Medicines Co. price target raised to $60 from $52 at Oppenheimer

Oppenheimer analyst Jay Olson raised his price target for The Medicines Co. to $60 from $52 after the company presented details from the Phase 3 ORION-11 trial at ESC after recent topline results. The analyst believes the results "significantly de-risk" ORION-9 and -10 data to read-out sequentially in late Q3, and views The Medicines Co. as an "attractive" potential M&A target. Based on positive ORION-11 details, he also increased his Probability of Success for inclisiran to 80% from 70%. Olson reiterates an Outperform rating on the shares.

MDCO The Medicines Co.
$41.92

-1.05 (-2.44%)

08/26/19
ROTH
08/26/19
NO CHANGE
Target $72
ROTH
Buy
The Medicines Co. press release indicates 'stellar data set,' says Roth Capital
The Medicines Co. this morning unveiled that ORION-11 met all primary and key secondary endpoints while demonstrating a "clean sweep" with a favorable safety profile, Roth Capital analyst Yasmeen Rahimi tells investors in a research note. Although the top-line release was bare boned due to the stringent ESC Congress embargo policy, the press release language foreshadows a "stellar data set," contends the analyst. Rahimi views the report as a "strong win" and believes inclisiran's "durable and consistent" LDL-C reduction is poised to translate into improved cardiovascular outcomes. The analyst keeps a Buy rating on The Medicines Co. with a $72 price target.
08/26/19
PIPR
08/26/19
NO CHANGE
PIPR
The Medicines Co. data a positive for Alnylam, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff reiterated an Overweight rating and $142 price target on Alnylam Pharmaceuticals (ALNY) after its partner, The Medicines Co. (MDCO), announced positive top-line data from its Phase III ORION-11 trial of inclisiran. The analyst believes inclisiran will be approved next year, and noted that Alnylam is eligible for "milestones plus up to double-digit royalties."
09/02/19
PIPR
09/02/19
NO CHANGE
Target $145
PIPR
Overweight
Alnylam price target raised to $145 from $142 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Alnylam (ALNY) to $145 from $142 after partner The Medicine Co. (MDCO) presented positive Phase III ORION-11 data on inclisiran in 1,617 ASCVD patients at the European Society of Cardiology Congress in Paris. The analyst remains confident in inclisiran approval next year and Alnylam is eligible for milestones plus up to double-digit royalties. He reiterates an Overweight rating on Alnylam shares.
09/03/19
SBSH
09/03/19
NO CHANGE
Target $55
SBSH
Buy
The Medicines Co. price target raised to $55 from $48 at Citi
Citi analyst Joel Beatty raised his price target for The Medicines Co. to $55 from $48 following this weekend's detailed Phase 3 inclisiran data. The results suggest that inclisran is comparable on safety and efficacy to the approved PCSK9 antibody agents, Beatty tells investors in a research note. The analyst's new price target assumes a 100% probability of success for the drug. He keeps a Buy rating on The Medicines Co.

TODAY'S FREE FLY STORIES

BX

Blackstone

$52.93

-0.57 (-1.07%)

13:30
09/18/19
09/18
13:30
09/18/19
13:30
Periodicals
Blackstone near $2.9B deal to buy Great Wolf Resorts, Bloomberg says »

Privately held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 26

    Sep

RUBI

Rubicon Project

$9.36

-0.05 (-0.53%)

, TLRA

Telaria

$8.03

-0.195 (-2.37%)

13:26
09/18/19
09/18
13:26
09/18/19
13:26
Recommendations
Rubicon Project, Telaria, Trade Desk analyst commentary  »

Google auction shift…

RUBI

Rubicon Project

$9.36

-0.05 (-0.53%)

TLRA

Telaria

$8.03

-0.195 (-2.37%)

TTD

Trade Desk

$209.29

-3.72 (-1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 30

    Sep

  • 07

    Nov

  • 12

    Nov

FDX

FedEx

$149.76

-23.77 (-13.70%)

13:25
09/18/19
09/18
13:25
09/18/19
13:25
Downgrade
FedEx rating change  »

FedEx downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 30

    Sep

  • 01

    Oct

  • 13

    Nov

  • 17

    Dec

13:25
09/18/19
09/18
13:25
09/18/19
13:25
Conference/Events
The SEC to hold a meeting to hear oral arguments »

The Commission will hear…

SOLO

ElectraMeccanica

$2.40

0.04 (1.69%)

13:24
09/18/19
09/18
13:24
09/18/19
13:24
Initiation
ElectraMeccanica initiated  »

ElectraMeccanica…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UN

Unilever; also tag UL

$60.45

0.01 (0.02%)

, PG

Procter & Gamble

$121.47

0.32 (0.26%)

13:23
09/18/19
09/18
13:23
09/18/19
13:23
Recommendations
Unilever; also tag UL, Procter & Gamble, Unilever; also tag UN, Reckitt Benckiser, Henkel, L'Oreal analyst commentary  »

EU Household &…

UN

Unilever; also tag UL

$60.45

0.01 (0.02%)

PG

Procter & Gamble

$121.47

0.32 (0.26%)

UL

Unilever; also tag UN

$61.51

0.05 (0.08%)

RBGLY

Reckitt Benckiser

$0.00

(0.00%)

HENKY

Henkel

$0.00

(0.00%)

LRLCY

L'Oreal

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 08

    Oct

  • 18

    Oct

  • 12

    Nov

NRC

National Research Corporation

$63.59

1.59 (2.56%)

13:23
09/18/19
09/18
13:23
09/18/19
13:23
Hot Stocks
National Research Corporation director Donald Berwick sold over $433K in shares »

National Research…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$188.14

0.01 (0.01%)

, TWTR

Twitter

$42.66

-0.59 (-1.36%)

13:22
09/18/19
09/18
13:22
09/18/19
13:22
On The Fly
#SocialStocks: Facebook clarifies oversight structure, Snap in talks to add news »

Welcome to…

FB

Facebook

$188.14

0.01 (0.01%)

TWTR

Twitter

$42.66

-0.59 (-1.36%)

SNAP

Snap

$16.77

-0.1 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 18

    Sep

  • 20

    Sep

  • 24

    Sep

  • 27

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
09/18/19
09/18
13:17
09/18/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
09/18/19
09/18
13:16
09/18/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TYL

Tyler Technologies

$259.19

-0.47 (-0.18%)

13:15
09/18/19
09/18
13:15
09/18/19
13:15
Conference/Events
Tyler Technologies management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 25

    Sep

  • 26

    Sep

BRKR

Bruker

$43.21

0.34 (0.79%)

13:14
09/18/19
09/18
13:14
09/18/19
13:14
Conference/Events
Bruker management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

RST

Rosetta Stone

$18.99

-0.22 (-1.15%)

13:13
09/18/19
09/18
13:13
09/18/19
13:13
Conference/Events
Rosetta Stone management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

CYRX

Cryoport

$17.92

0.17 (0.96%)

13:07
09/18/19
09/18
13:07
09/18/19
13:07
Hot Stocks
Breaking Hot Stocks news story on Cryoport »

Cryoport CEO says Seeking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYRX

Cryoport

$17.92

0.17 (0.96%)

, GILD

Gilead

$65.78

-0.39 (-0.59%)

13:05
09/18/19
09/18
13:05
09/18/19
13:05
On The Fly
Meet Cryoport: A Fly exclusive interview with CEO Jerry Shelton »

In an exclusive interview…

CYRX

Cryoport

$17.92

0.17 (0.96%)

GILD

Gilead

$65.78

-0.39 (-0.59%)

NVS

Novartis

$86.46

-0.11 (-0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 18

    Sep

  • 19

    Sep

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

CYRX

Cryoport

$17.92

0.17 (0.96%)

13:04
09/18/19
09/18
13:04
09/18/19
13:04
Hot Stocks
Breaking Hot Stocks news story on Cryoport »

Shelton sees Cryoport…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYRX

Cryoport

$17.92

0.17 (0.96%)

13:04
09/18/19
09/18
13:04
09/18/19
13:04
Hot Stocks
Breaking Hot Stocks news story on Cryoport »

Cryoport, Vineti…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYRX

Cryoport

$17.92

0.17 (0.96%)

, GILD

Gilead

$65.80

-0.37 (-0.56%)

13:04
09/18/19
09/18
13:04
09/18/19
13:04
Hot Stocks
Breaking Hot Stocks news story on Cryoport, Gilead, Novartis »

Gilead, Novartis…

CYRX

Cryoport

$17.92

0.17 (0.96%)

GILD

Gilead

$65.80

-0.37 (-0.56%)

NVS

Novartis

$86.46

-0.11 (-0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 18

    Sep

  • 19

    Sep

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

AEGN

Aegion

$20.77

-0.46 (-2.17%)

13:03
09/18/19
09/18
13:03
09/18/19
13:03
Hot Stocks
Aegion unit awarded $9.3M contract from MWRD in Denver »

Aegion announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

BYND

Beyond Meat

$157.51

-2.86 (-1.78%)

, QSR

Restaurant Brands

$73.77

-0.08 (-0.11%)

13:01
09/18/19
09/18
13:01
09/18/19
13:01
Periodicals
Tim Hortons to pull back on Beyond Meat offerings, Journal de Montreal says »

A translation of a French…

BYND

Beyond Meat

$157.51

-2.86 (-1.78%)

QSR

Restaurant Brands

$73.77

-0.08 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

BX

Blackstone

$52.97

-0.53 (-0.99%)

13:01
09/18/19
09/18
13:01
09/18/19
13:01
Periodicals
Breaking Periodicals news story on Blackstone »

Blackstone near $2.9B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 26

    Sep

RYAAY

Ryanair

$61.95

-0.14 (-0.23%)

12:53
09/18/19
09/18
12:53
09/18/19
12:53
Initiation
Ryanair initiated  »

Ryanair initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$300.17

-0.77 (-0.26%)

12:47
09/18/19
09/18
12:47
09/18/19
12:47
Hot Stocks
Gundlach sees 'increasing probability' of recession before 2020 election »

Jeffrey Gundlach of…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$300.17

-0.77 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,228.87

-0.74 (-0.06%)

, GOOGL

Alphabet Class A

$1,228.96

-0.41 (-0.03%)

12:45
09/18/19
09/18
12:45
09/18/19
12:45
Hot Stocks
Google says YouTube Masthead coming to TV screen »

Google said in a blog…

GOOG

Alphabet

$1,228.87

-0.74 (-0.06%)

GOOGL

Alphabet Class A

$1,228.96

-0.41 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 24

    Sep

  • 27

    Oct

JPM

JPMorgan

$118.64

0.09 (0.08%)

12:45
09/18/19
09/18
12:45
09/18/19
12:45
Periodicals
JPMorgan's Dimon says his gut says a recession is 'not imminent,' CNBC reports »

JPMorgan Chairman and CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 15

    Oct

  • 27

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.